Applications of 4-Bromo-3-Chlorophenyl Isothiocyanate in Industrial Manufacturing

4-Bromo-3-Chlorophenyl Isothiocyanate serves as a critical intermediate in several demanding specialty chemical production processes. Its unique electronic properties and reactivity profile support precision synthesis in pharmaceutical, agrochemical, and advanced materials sectors. Below, we detail the primary industrial applications based on proven downstream use, with a focus on quality and technical performance.

1. Pharmaceutical Active Ingredient Synthesis

This intermediate plays an essential role in route-specific pharmaceutical syntheses, especially for targeted heterocyclic APIs used to treat disorders in neurology and oncology. Its halogenated structure enables selective isothiocyanation steps during medicinal chemistry route development and late-stage diversification. Downstream manufacturers rely on stringent control of stoichiometry and purity to meet regulatory expectations throughout API production.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients
• U.S. Pharmacopeia (USP) relevant sections (specific API monograph)
• European Pharmacopeia (Ph. Eur.) compliance for synthetic intermediates
• Process validation and analytical traceability for audit readiness

Typical usage ratio

• 0.5–2.8 molar equivalents, adjusted based on stepwise conversion efficiency and impurity control; titration determined by the specific coupling or functionalization route

Downstream process integration

• Added during the isothiocyanate coupling stage in the presence of base or catalyst; incorporated under anhydrous or inert conditions to control side-reactions and yield

Final product types

• N-substituted heterocycles (e.g., benzothiazoles, dihydroquinazolines, thiourea derivatives)
• Orally administered or parenteral APIs for central nervous system and cancer treatment classes
• Advanced pharmaceutical intermediates for dedicated CDMO projects

2. Agrochemical Sulfonylurea and Thiadiazole Precursor

Major crop protection R&D facilities use this isothiocyanate for synthesizing custom herbicidal and fungicidal actives, notably sulfonylureas and 1,2,4-thiadiazoles. Its halogen substitution pattern supports both high selectivity in condensation reactions and manageable downstream purification, enabling manufacturers to achieve tight residue specifications in line with global regulatory residue limits.

Industry compliance standards

• FAO/WHO Specification for Pesticide Technical Materials
• ISO 9001:2015 for production quality management
• EU Regulation (EC) No 1107/2009 for placing plant protection products on the market
• U.S. EPA 40 CFR Part 158 Data Requirements for Pesticides

Typical usage ratio

• 0.8–1.5 equivalents, determined by the stoichiometry of the cyclization or condensation transformation; adjusted according to yield optimization protocols established from pilot studies

Downstream process integration

• Introduced post-halogenation to enable well-controlled nucleophilic addition and ring closure for bioactive scaffold development; process parameters often include solvent selection and temperature stasis to minimize byproducts

Final product types

• Sulfonylurea herbicide technical concentrates
• 1,2,4-Thiadiazole fungicidal actives for seed treatment
• Agrochemical intermediates supplied to toll formulators
• Regulatory reference samples for global residue studies

3. Diagnostic Reagent Functionalization

Laboratory reagent and diagnostic kit producers leverage this compound for site-selective isothiocyanation of aromatic amines and peptides in solid-phase and solution-phase bioconjugation. Its reactivity profile supports stable antibody or small-molecule immobilization for in vitro diagnostic (IVD) probes, maintaining test specificity and signal integrity across kit shelf life.

Industry compliance standards

• EN ISO 13485:2016 for medical device QMS (applicable to IVD reagents)
• 21 CFR Part 820 – FDA Quality System Regulation
• REACH Annex XVII (chemical safety and workplace handling)
• CLSI EP05 for evaluation of precision in IVD reagents

Typical usage ratio

• 0.2–1.0 equivalents per accessible amine group, experimentally established during probe development, with adjustments to maintain functional group excess avoidance and maximize labeling yield

Downstream process integration

• Employed in final bioconjugation stages for covalent linkage of isothiocyanate functional groups to peptide, protein, or dye backbones under controlled pH and temperature conditions to safeguard reagent activity

Final product types

• Pre-functionalized diagnostic labeling reagents
• Antibody and peptide conjugates for immunoassays (ELISA, lateral flow)
• Bulk components for rapid test kit assembly
• Research-use-only (RUO) and CE-IVD labeled probe sets

4. Liquid Crystal Material Intermediate

Key formulators of advanced display substrates integrate this raw material for synthetic modification steps in the production of highly anisotropic mesogenic compounds. Its role centers on the introduction of halogenated isothiocyanate moieties to improve thermal and electro-optic performance in high-resolution and fast-switching liquid crystal panels.

Industry compliance standards

• RoHS Directive 2011/65/EU (for hazardous substance limitation in electronics)
• IEC 61249-2-21 for base materials in display manufacturing
• ISO 9001:2015 for finished display material process control
• Customer-specific incoming quality control (IQC) protocols for electronic components

Typical usage ratio

• 0.45–1.0 molar ratio relative to aromatic co-monomers, balanced to achieve desired birefringence, viscosity, and clearing point for end-use display calibration

Downstream process integration

• Added to organic synthesis streams during late-stage functionalization before mesogen mixture purification; process includes high-vacuum distillation and repeated crystallization steps to ensure compound homogeneity and low trace impurity

Final product types

• Mesogenic compound intermediates for TFT-LCD and OLED displays
• Final liquid crystal fluid mixtures for panel filling and assembly
• LC alignment and spacer agents for precision microdisplay manufacturing